1. Serum susceptibility of Escherichia coli and its association with patient clinical outcomes.
- Author
-
Poteete, Orianna, Cox, Phillip, Ruffin, Felicia, Sutton, Granger, Brinkac, Lauren, Clarke, Thomas H., Fouts, Derrick E., Fowler Jr., Vance G., and Thaden, Joshua T.
- Subjects
- *
ESCHERICHIA coli , *HIGH throughput screening (Drug development) , *SEPTIC shock , *WORKBENCHES , *HOSPITAL mortality , *ESCHERICHIA coli physiology - Abstract
The innate immune system eliminates bloodstream pathogens such as Escherichia coli in part through complement protein deposition and subsequent bacterial death (i.e., "serum killing"). Some E. coli strains have developed mechanisms to resist serum killing, though the extent of variation in serum killing among bloodstream infection (BSI) isolates and the clinical impact of this variation is not well understood. To address this issue, we developed a novel assay that uses flow cytometry to perform high throughput serum bactericidal assays (SBAs) with E. coli BSI isolates (n = 183) to define the proportion of surviving bacteria after exposure to serum. We further determined whether E. coli resistance to serum killing is associated with clinical outcomes (e.g., in-hospital attributable mortality, in-hospital total mortality, septic shock) and bacterial genotype in the corresponding patients with E. coli BSI. Our novel flow cytometry-based SBA performed similarly to a traditional SBA, though with significantly decreased hands-on bench work. Among E. coli BSI isolates, the mean proportion that survived exposure to 25% serum was 0.68 (Standard deviation 0.02, range 0.57–0.93). We did not identify associations between E. coli resistance to serum killing and clinical outcomes in our adjusted models. Together, this study describes a novel flow cytometry-based approach to the bacterial SBA that allowed for high-throughput testing of E. coli BSI isolates and identified high variability in resistance to serum killing among a large set of BSI isolates. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF